Catalyst Moderated a Panel at the American Society of Gene & Cell Therapy Policy Summit

Catalyst Founder and CEO, Nancy Myers, moderated a panel on Thursday, September 24th, 2020 at the (virtual) ASGCT Policy Summit. The panel was on “Overcoming Regulatory Challenges in Gene Therapy Development.”

The panelists and their presentation topics are:

• Anne-Virginie Eggimann, Senior Vice-President, Regulatory Science, bluebird bio
  “Regulatory considerations to improve gene therapy development throughout life cycle”
• Ying Huang, Ph.D., Pharmacologist, Pharmacology/Toxicology Branch, FDA
  “Selecting appropriate animal models for clinical success”
• Becky Schweighardt, Ph.D., Senior Director, Immunogenicity Assessment, BioMarin
  “Addressing immunogenicity in clinical trials”

For more information and to register, click HERE.